Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Trump Panel Urges More Treatment Options to Fight Opioid Crisis

Toni Clarke  |  November 2, 2017

(Reuters)—A panel convened by U.S. President Donald Trump to tackle the opioid crisis called on Wednesday for more treatment programs, tighter prescribing guidelines and additional drug courts to help reduce overdose deaths.

The commission, led by New Jersey Governor Chris Christie, said the recommendations would require funding by Congress but did not recommend an amount. Trump last week declared the opioid crisis a public health emergency.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Public health experts broadly welcomed the proposed measures.

“This sounds to me like a very progressive and very needed move,” said Professor Kosali Simon, a health economist at Indiana University, of the recommendations.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

But Paul Hanly, a New York lawyer representing local governments in a legal battle against opioid makers, said recommendations, while laudable, would be “toothless” without substantial funding.

Opioids include prescription painkillers, heroin and fentanyl. More than 100 Americans die daily from overdoses, according to federal data.

The commission recommended a national media campaign to encourage opioid addicts to seek help. Only 10.6 percent of people who need treatment get it, the report noted.

The media campaign would encourage addicts to “stop being afraid or ashamed of seeking help when facing their addiction.”

It urged expansion of drug courts, in which addicts convicted of non-violent offenses are diverted into programs that combine treatment with mandatory drug testing and court appearances.

The commission said drug courts, which are currently offered in just 44 percent of U.S. counties, should embrace medication-assisted treatment to improve outcomes.

The U.S. Food and Drug Administration last week announced plans to encourage wider use of substitute opioids such as methadone and buprenorphine, which do not induce a high and are used to help people through drug addiction recovery.

Still, Dr. Stefan Kertesz of the University of Alabama at Birmingham said communities often lack treatment facilities where drug courts can send addicts. And many drug courts charge fees that make them unaffordable for many.

“Drug courts often function as pay to play,” Kertesz said. “Only people who can come up with money can escape a prison sentence.”

The report recommended expanding the ranks of emergency responders allowed to administer naloxone to treat overdoses. It also encouraged stricter prescribing guidelines for physicians.

 

 

Share: 

Filed under:Legislation & Advocacy Tagged with:more treatment optionsnational opioid addiction epidemicNew Jersey Governor Chris Christieopioid crisis

Related Articles
    ah_designs / shutterstock.com

    The Perils of Pain Meds Revisited

    December 18, 2018

    More than 10 years ago, I wrote a commentary in The Rheumatologist, called “Perils of Pain Meds,” about the over-prescribing of opioid analgesics for common causes of chronic noncancer pain, which was a major contributor to the opioid epidemic.1 Since that time, although there has been a greater than 20% decrease in opioid prescribing, the…

    Speak Out Rheum: How Did We Go So Wrong with Opioid Prescribing?

    November 4, 2022

    I have been listening to The Fighter Pilot Podcast because my fantasy career would have been to fly a jet fighter plane (not even remotely possible, given my constitution). I learned that when an aircraft accident occurs, a mishap board is convened, not to assign blame but to try to learn what went wrong and…

    Lost and found

    The History of ACE Inhibitors in Scleroderma Renal Crisis

    February 16, 2021

    Scleroderma renal crisis is a true medical emergency in rheumatology, one that requires prompt diagnosis and treatment. Here, we review the historic introduction of the angiotensin-converting enzyme inhibitors in this context, and highlight management and key questions moving forward. Background Awareness of renal disease in scleroderma dates back many years. The revered physician William Osler…

    Rheumatologists Respond to Prescription Opioid Analgesic Crisis

    May 16, 2017

    The alarming statistics on prescription opioid overdoses are well known to medical professionals, thanks to the Centers for Disease Control and Prevention (CDC)’s widely cited finding that deaths from opioid analgesics have increased fourfold since 1999.1 Half of all fatal drug overdoses now involve opioids prescribed by a doctor. Meanwhile, a lack of rigorous research…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences